Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 9 July 2009, Vol. 114, No. 2, pp. 469-477.
Prepublished online as a Blood First Edition Paper on May 13, 2009; DOI 10.1182/blood-2008-12-193581.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Methods and Figures
Right arrow All Versions of this Article:
blood-2008-12-193581v1
114/2/469    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skuli, N.
Right arrow Articles by Keith, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skuli, N.
Right arrow Articles by Keith, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted December 9, 2008
Accepted April 28, 2009

Endothelial deletion of hypoxia inducible factor-2alpha (HIF-2{alpha}) alters vascular function and tumor angiogenesis

Nicolas Skuli, Liping Liu, Anja Runge, Tao Wang, Lijun Yuan, Sunny Patel, Luisa Iruela-Arispe, M. Celeste Simon*, and Brian Keith

Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, United States
Howard Hughes Medical Institute, University of Pennsylvania, Philadelphia, PA, United States
Penn Cardiovascular Institute, University of Pennsylvania, Philadelphia, PA, United States
Department of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, United States
Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA, United States
Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, PA, United States

* Corresponding author; email: celeste2{at}mail.med.upenn.edu.

Hypoxia inducible factor-2alpha (HIF-2{alpha}) is highly expressed in embryonic vascular endothelial cells (ECs) and activates the expression of target genes whose products modulate vascular function and angiogenesis. In this report, we describe a genetic model designed to test the physiological consequences of deleting HIF-2{alpha} in murine endothelial cells. Surprisingly, mice with HIF-2{alpha} deficient ECs developed normally but displayed a variety of phenotypes including increased vessel permeability, aberrant endothelial cell ultrastructure, and pulmonary hypertension. Moreover, these animals exhibited defective tumor angiogenesis associated with increased hypoxic stress and tumor cell apoptosis. Immortalized HIF-2{alpha} deficient ECs displayed decreased adhesion to extra-cellular matrix proteins and expressed reduced levels of transcripts encoding fibronectin, integrins, endothelin B receptor (ET-B), angiopoietin 2 (Ang2) and delta-like ligand 4 (Dll4). Together, these data identify unique cell-autonomous functions for HIF-2{alpha} in vascular endothelial cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020